Description
In the United States, the Spinal Cord Injury Model Systems (SCIMS), Department of Veterans Affairs, and academic medical centers set the standard of care for SCI medicine, providing an integrated, multidisciplinary network to care for patients with spinal cord injury. For many of those living with SCI however, these centers are geographically isolated and inaccessible. As a result, their health and functional outcomes can dramatically differ from what should be expected. This session will review some clinical cases in the community and private practice-based settings, where in the absence of SCI expertise, basic medical issues like autonomic dysreflexia and neurogenic bladder may go undiagnosed and untreated. We will close with a discussion about ways to improve awareness and overcome geographical barriers in accessing SCI care.
Learning Objectives
After completing this live activity, the participant should be able to:
- Identify common gaps between model system SCI standards of care and real-world community practice.
- Apply pragmatic troubleshooting strategies for autonomic dysreflexia, neurogenic bladder, and other high-risk SCI complications in resource-limited settings.
- Develop approaches to strengthen collaboration between academic centers and community providers to improve outcomes for individuals living with SCI.
Accreditation Statement
The American Academy of Physical Medicine and Rehabilitation (AAPM&R) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Credit Designation
The American Academy of Physical Medicine and Rehabilitation (AAPM&R) designates this live activityfor a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement
In accordance with ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, AAPM&R requires all individuals who are in a position to affect the strategic direction of AAPM&R and/or control the content of an educational activity to disclose all financial relationships with any ineligible company within the last 24 months. The ACCME defines an “ineligible company” as any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Disclosures are made in written form prior to the start of the educational activity, and any potential conflicts of interest that exist are mitigated prior to the start of the activity through AAPM&R’s Conflict of Interest Disclosure and Resolution Policy Process. Individuals in a position to affect the strategic direction of AAPM&R and/or control content and their disclosed financial relationships are listed below.
No other planners, faculty, or individuals in control of content disclosed any relevant financial relationships.
Principle Faculty
Name, Credential(s): Company Name, Nature of financial relationship;
Chris Bo MD, FAAPMR - Nothing to Disclose
Shane Stone MD, FAAPMR - Nothing to Disclose
AAPM&R Medical Education Committee
Name, Credential(s): Company Name, Nature of financial relationship
Rachel Brakke Holman, MD - Nothing to Disclose
Sarah M. Eickmeyer, MD - Nothing to Disclose
Chelsea D. Frost, MD, MS - Nothing to Disclose
David J. Haustein, MBA,MD,MBA - Relationships to Disclose
Sarah K. Hwang, MD - Nothing to Disclose
Ravi E. Kasi, MD - Nothing to Disclose
Caroline Pupke, DO - Nothing to Disclose
Monica E. Rho, MD - Nothing to Disclose
McCasey R. Smith, MD - Nothing to Disclose
Jennifer A. Soo Hoo, MD - Nothing to Disclose
Brionn K. Tonkin, MD - Nothing to Disclose
Stephanie Tow, MD - Nothing to Disclose
Justin L. Weppner, DO - Nothing to Disclose
Alexandra G. Wolfe, DO - Nothing to Disclose
FDA Disclosures
All faculty members for this activity have disclosed they do not intend to discuss or demonstrate any pharmaceutical or medical device for which FDA clearance has not been approved.